最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/9/29。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 20
- 預計賣出市值
- $1,358 萬
- 賣方
- 8
- 公司
- 1
- 依 10b5-1 計畫
- 16
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/7/216:31 ET | Jeff Knight高階主管 | 4.74 萬 | $183.4 萬 | 2026/7/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/7/216:29 ET | Rogerio Vivaldi Coelho董事 | 6,000 | $23.2 萬 | 2026/7/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/6/1716:27 ET | Stephanie Okey董事 | 6,900 | $24.1 萬 | 2026/6/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/5/416:26 ET | Jeff Knight高階主管 | 9,485 | $37.0 萬 | 2026/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/4/1416:37 ET | Jeff Knight高階主管 | 2.09 萬 | $80.8 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/4/1316:36 ET | Jeff Knight高階主管 | 4,434 | $17.5 萬 | 2026/4/1310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/4/816:49 ET | Jeff Knight高階主管 | 8.52 萬 | $327.1 萬 | 2026/4/810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/1816:30 ET | Dana Pizzuti高階主管 | 2.48 萬 | $93.8 萬 | 2026/3/1810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/1609:24 ET | Jeff Knight高階主管 | 2.51 萬 | $94.1 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/1609:23 ET | Stephen Betz高階主管 | 2.65 萬 | $99.4 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/1609:23 ET | Richard Scott Struthers董事 · 高階主管 | 4.50 萬 | $168.8 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/1216:28 ET | Rogerio Vivaldi Coelho董事 | 5,000 | $18.5 萬 | 2026/3/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/316:32 ET | Stephanie S Okey董事 | 3,000 | $12.2 萬 | 2026/3/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/3/210:28 ET | Tobin Schilke高階主管 | 6,800 | $28.0 萬 | 2026/3/2 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/2/216:32 ET | Dana Pizzuti高階主管 | 1.00 萬 | $49.9 萬 | 2026/2/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/1/516:43 ET | Isabel Kalofonos高階主管 | 2,500 | $11.7 萬 | 2026/1/510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2026/1/216:31 ET | Dana Pizzuti高階主管 | 5,000 | $23.3 萬 | 2026/1/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2025/12/116:37 ET | Dana Pizzuti高階主管 | 5,000 | $22.8 萬 | 2025/12/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2025/11/316:26 ET | Dana Pizzuti高階主管 | 5,000 | $21.8 萬 | 2025/11/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | 2025/10/116:30 ET | Dana Pizzuti高階主管 | 5,000 | $20.8 萬 | 2025/10/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |